Volume 98, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Although (), the causative agent of lymphatic filariasis, is endemic throughout Mali, the prevalence of microfilaremia (Mf) can vary widely between villages despite similar prevalence of infection as assessed by circulating antigen. To examine this variation, cross-sectional data obtained during screening prior to an interventional study in two neighboring villages in Mali were analyzed. The overall prevalence of , as assessed by CAg (circulating antigen), was 50.3% among 373 participants, aged 14-65. Mf-positive and negative individuals appeared randomly distributed across the two villages (Moran’s I spatial statistic = -0.01, Z score =0.1, P>0.05). Among the 187 subjects positive for CAg, 117 (62.5%) had detectable microfilaremia ( Mf) and 64 (34.2%) had detectable microfilaremia. The prevalence of microfilaremia was 73.4% in the Mf-positive group (as compared to 56.9% in the Mf-negative group; p=0.01), and median Mf load was increased in co-infected subjects (267Mf/ml vs 100 Mf/ml; p<0.001). In multivariate analysis, village of residence, Mf positivity and gender were significantly associated with Mf positivity. After controlling for age, gender, and village of residence, the odds of being Mf positive was 2.67 times higher in positive individuals (95% confidence interval [1.42–5.01]). Given the geographical overlap between and in Africa, a better understanding of the distribution and prevalence of could assist national lymphatic filariasis control programs in predicting areas of high Mf prevalence that may require closer surveillance.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. World Health Organization, 2016. WHO | Lymphatic Filariasis. Geneva, Switzerland: WHO. Available at: www.who.org/filariasis. Accessed January 26, 2017.
  2. Cano J, 2014. The global distribution and transmission limits of lymphatic filariasis: past and present. Parasit Vectors 7: 466. [Google Scholar]
  3. Stanton MC, Best A, Cliffe M, Kelly-Hope L, Biritwum N-K, Batsa L, Debrah A, , 2016. Situational analysis of lymphatic filariasis morbidity in Ahanta West District of Ghana. Trop Med Int Health 21: 236244. [Google Scholar]
  4. Stensgaard A-S, 2016. Ecological drivers of Mansonella perstans infection in Uganda and patterns of co-endemicity with lymphatic filariasis and malaria. PLoS Negl Trop Dis 10: e0004319. [Google Scholar]
  5. Chesnais CB, Missamou F, Pion SD, Bopda J, Louya F, Majewski AC, Fischer PU, Weil GJ, Boussinesq M, , 2014. A case study of risk factors for lymphatic filariasis in the Republic of Congo. Parasit Vectors 7: 300. [Google Scholar]
  6. Boyd A, Won KY, McClintock SK, Donovan CV, Laney SJ, Williams SA, Pilotte N, Streit TG, Beau de Rochars MVE, Lammie PJ, , 2010. A community-based study of factors associated with continuing transmission of lymphatic filariasis in Leogane, Haiti. PLoS Negl Trop Dis 4: e640. [Google Scholar]
  7. Dembélé M, 2012. Implementing preventive chemotherapy through an integrated national neglected tropical disease control program in Mali. PLoS Negl Trop Dis 6: e1574. [Google Scholar]
  8. Richards FO, 2011. Epidemiological and entomological evaluations after six years or more of mass drug administration for lymphatic filariasis elimination in Nigeria. PLoS Negl Trop Dis 5: e1346. [Google Scholar]
  9. Slater H, Michael E, , 2013. Mapping, bayesian geostatistical analysis and spatial prediction of lymphatic filariasis prevalence in Africa. PLoS One 8: e71574. [Google Scholar]
  10. Reimer LJ, 2013. Insecticidal bed nets and filariasis transmission in Papua New Guinea. N Engl J Med 369: 745753. [Google Scholar]
  11. Kelly-Hope LA, Molyneux DH, Bockarie MJ, , 2013. Can malaria vector control accelerate the interruption of lymphatic filariasis transmission in Africa; capturing a window of opportunity? Parasit Vectors 6: 39. [Google Scholar]
  12. Dembele B, 2010. Use of high‐dose, twice‐yearly albendazole and ivermectin to suppress Wuchereria bancrofti microfilarial levels. Clin Infect Dis 51: 12291235. [Google Scholar]
  13. Onapa AW, Simonsen PE, Pedersen EM, Okello DO, , 2001. Lymphatic filariasis in Uganda: baseline investigations in Lira, Soroti and Katakwi districts. Trans R Soc Trop Med Hyg 95: 161167. [Google Scholar]
  14. Wattal S, Dhariwal AC, Ralhan PK, Tripathi VC, Regu K, Kamal S, Lal S, , 2007. Evaluation of Og4C3 antigen ELISA as a tool for detection of bancroftian filariasis under lymphatic filariasis elimination programme. J Commun Dis 39: 7584. [Google Scholar]
  15. Grove DI, Valeza FS, Cabrera BD, , 1978. Bancroftian filariasis in a Philippine village: clinical, parasitological, immunological, and social aspects. Bull World Health Organ 56: 975984. [Google Scholar]
  16. Pani SP, Balakrishnan N, Srividya A, Bundy DA, Grenfell BT, , 1991. Clinical epidemiology of bancroftian filariasis: effect of age and gender. Trans R Soc Trop Med Hyg 85: 260264. [Google Scholar]
  17. Keiser PB, 2003. Clinical characteristics of post-treatment reactions to ivermectin/albendazole for Wuchereria bancrofti in a region co-endemic for Mansonella perstans. Am J Trop Med Hyg 69: 331335. [Google Scholar]
  18. Simonsen PE, Onapa AW, Asio SM, , 2011. Mansonella perstans filariasis in Africa. Acta Trop 120: S109S120. [Google Scholar]
  19. Uttah E, Ibeh DC, , 2011. Multiple filarial species microfilaraemia: a comparative study of areas with endemic and sporadic onchocerciasis. J Vector Borne Dis 48: 197204. [Google Scholar]
  20. Coulibaly YI, 2009. A randomized trial of doxycycline for Mansonella perstans infection. N Engl J Med 361: 14481458. [Google Scholar]
  21. Keiser PB, Coulibaly Y, Kubofcik J, Diallo AA, Klion AD, Traoré SF, Nutman TB, , 2008. Molecular identification of wolbachia from the filarial nematode Mansonella perstans. Mol Biochem Parasitol 160: 123128. [Google Scholar]
  22. Pion SDS, Clarke P, Filipe JAN, Kamgno J, Gardon J, Basáñez M-G, Boussinesq M, , 2006. Co-infection with Onchocerca volvulus and Loa loa microfilariae in central Cameroon: are these two species interacting? Parasitology 132: 843854. [Google Scholar]
  23. Coulibaly YI, 2015. The impact of six annual rounds of mass drug administration on Wuchereria bancrofti infections in humans and in mosquitoes in Mali. Am J Trop Med Hyg 93: 356360. [Google Scholar]

Data & Media loading...

  • Received : 20 Nov 2017
  • Accepted : 13 Mar 2018
  • Published online : 30 Apr 2018

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error